The dream of a disease free world

Our approach with MicroMTx002 aims to treat a variety of cancers by leveraging the power of mRNA technology

Cancer is a disease caused due to a mutation in the DNA within cells that causes them to multiply at an abnormal rate and is one of the leading causes of death in the world. Cancer treatment vaccines work by boosting the immune systems ability to find and target cancer specific antigens.

Current Line of Treatment



Monoclonal Antibodies
  • High chance of reoccurrence
  • Long duration therapy


  • Not targeted
  • Serious side effects
  • Painful


  • Invasive
  • Selective use cases

Significant Worldwide Burden

Annual Cases


6.9 m

MicroMTx002 is a next-generation mRNA cancer vaccine that is based on the most wide spread and well known oncogenes and cancer specific antigens making it universal in nature. We are currently developing MicroMTx002 to treat multiple cancers with the first targets being lung, pancreatic, colorectal, skin, head and neck and prostate cancer.

Check out some of the other next-generation living therapeutics that are being developed by Micro CRISPR.